Article

Improving Treatment and Outcomes in Spinal Muscular Atrophy Patients

https://www.pharmacytimes.org/on-demand/improving-treatment-and-outcomes-in-spinal-muscular-atrophy-patients

https://www.pharmacytimes.org/on-demand/improving-treatment-and-outcomes-in-spinal-muscular-atrophy-patients

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Steven Daveluy, MD, dermatologist, Wayne State University
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
Emilie Aschenbrenner, PharmD, BCOP, Froedtert Health and the Medical College of Wisconsin
Related Content
FIT test | Image credit: TOimages - stock.adobe.com
August 15th 2025

Pharmacy-Based FIT Screening Could Boost Colorectal Cancer Detection

Pearl Steinzor
managed care cast banner
August 15th 2025

Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD

Mary Caffrey Skylar Jeremias Joseph Mikhael, MD
Roflumilast cream | Image Credit: © luchschenF-stock.adobe.com
August 15th 2025

Roflumilast Cream 0.05% Durable, Safe for Younger Pediatric Patients

Maggie L. Shaw
AJMC podcast banner
August 15th 2025

What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD

Hayden E. Klein Skylar Jeremias Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
While the findings suggest that switching to onasemnogene abeparvovec after non–gene therapy treatments could be beneficial to patients with spinal muscular atrophy, it is not clear which patients may benefit the most from switching therapies. | Image credit: Rochu_2008 - stock.adobe.com
August 15th 2025

Switching to Gene Therapy After Nusinersen or Risdiplam May Benefit Patients With SMA

Rose McNulty
Paper saying Medicaid eligibility | Image credit: Vitalii Vodolazskyi – stock.adobe.com
August 15th 2025

5 Key Takeaways on Medicaid Policy Changes From Savista’s Chief Strategy Officer

Hayden E. Klein Laxmi Patel

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo